Evidence map›Paper›PMID 40079653›Full record

ArticleActa oncologica (Stockholm, Sweden)2025

Multi-dimensional interpretable deep learning-radiomics based on intra-tumoral and spatial habitat for preoperative prediction of thymic epithelial tumours risk categorisation.

Yuhua Yang, Jia Cheng, Can Cui, Huijie Huang, Meiling Cheng, Jiayi Wang, Minjing Zuo

Abstract read
In one paragraph

Article in Acta oncologica (Stockholm, Sweden), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuhua Yang *Department of Radiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China; Jiangxi Provincial Key Laboratory of Intelligent Medical Imaging, Nanchang, China.
Jia Cheng *Department of Radiology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Can CuiDepartment of Radiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China; Jiangxi Provincial Key Laboratory of Intelligent Medical Imaging, Nanchang, China.
Huijie HuangDepartment of Radiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China; Jiangxi Provincial Key Laboratory of Intelligent Medical Imaging, Nanchang, China.
Meiling ChengDepartment of Radiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China; Jiangxi Provincial Key Laboratory of Intelligent Medical Imaging, Nanchang, China.
Jiayi WangDepartment of Radiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China; Jiangxi Provincial Key Laboratory of Intelligent Medical Imaging, Nanchang, China.
Minjing ZuoDepartment of Radiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China; Jiangxi Provincial Key Laboratory of Intelligent Medical Imaging, Nanchang, China. minjingzuo@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThis study aims to develop and compare combined models based on enhanced CT-based radiomics, multi-dimensional deep learning, clinical-conventional imaging and spatial habitat analysis to achieve accurate prediction of thymoma risk classification. MATERIALS AND

methods205 consecutive patients with thymoma confirmed by surgical pathology were recruited from three medical centers. Venous phase enhanced CT images were used to delineate the tumor, and radiomics, 2D and 3D deep learning models based on the whole tumor were established and feature extraction was performed. The tumors were divided into different sub-regions by K-means clustering method and the corresponding features were obtained. The clinical-conventional imaging data of the patients were collected and evaluated, and the univariate and multivariate analysis were used for screening. The above types of features were fused with each other to construct a variety of combined models. Quantitative indicators such as area under the receiver operating characteristic (ROC) curve (AUC) were calculated to evaluate the performance of the model.

resultsThe AUC of RDLCSM developed based on LightGBM classifier was 0.953 in the training cohort, 0.930 in the internal validation cohort, 0.924 and 0.903 in the two external validation cohorts, respectively. RDLCSM performs better than RDLM (AUC range: 0.831-0.890) and 2DLCSM (AUC range: 0.785-0.916) based on KNN. In addition, RDLCSM had the highest accuracy (0.818-0.882) and specificity (0.926-1.000).

interpretationThe RDLCSM, which combines whole-tumor radiomics, 2D and 3D deep learning, clinical-visual radiology, and subregional omics, can be used as a non-invasive tool to predict thymoma risk classification.

Indexed as

Deep LearningNeoplasms, Glandular and EpithelialThymus NeoplasmsTomography, X-Ray ComputedAdultAgedFemaleHumansMaleMiddle AgedRadiomicsRisk AssessmentROC Curve

Identifiers

PMID40079653
PMCPMC11971837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.